Advertisement
"We are delighted to continue our long-standing history with Bio-RadLaboratories," said John Kershaw, President, Sysmex America, Inc. "TheBio-Rad VARIANT II TURBO Link is a perfect complement to the Sysmex HST-Nhematology automation line. With the addition of A1c to our automation line,we can truly manage all the testing of the lavender top hematology sampletubes in the laboratory."
Advertisement
Sysmex's Lavender Top Management(TM) solution provides hematologylaboratories with the ability to conduct analysis of 90% of tests compatiblewith EDTA samples (i.e. CBC, Diff, Retic, ESR, A1c and other tests). Sysmexand Bio-Rad will work together to provide seamless service, training,installation and customer support services.
"We are pleased to work with Sysmex in offering this integrated testingsolution to clinical laboratories as it will enable them to provide superiordiabetes testing services to doctors and their patients throughout the UnitedStates," said John Goetz, Bio-Rad Vice President and Group Manager of ClinicalDiagnostics.
About HbA1c
The hemogolobin A1c (A1C) blood test, which measures the amount of glucoseattached to the hemoglobin in the red blood cell, can estimate how well bloodglucose levels have been controlled during the previous three to four months.Bio-Rad's test is the industry's gold standard technology in determining if apatient's diabetes is under control.
About Bio-Rad
Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), has remained at thecenter of scientific discovery for more than 50 years manufacturing anddistributing a broad range of products for the life science research andclinical diagnostics markets. The company is renowned worldwide amonghospitals, universities, major research institutions as well as biotechnologyand pharmaceutical companies for its commitment to quality and customerservice. Founded in 1952, Bio-Rad is headquartered in Hercules, California,and serves more than 85,000 research and industry customers worldwide throughits global network of operations. The company employs over 5,000 peopleglobally and had revenues of nearly $1.3 billion in 2006. For moreinformation, visit http://www.bio-rad.com.
About Sysmex America, Inc.
Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe,Japan), is a world leader in clinical laboratory systemization and solutions,including clinical diagnostics, automation and information systems. Servingcustomers for over 35 years, Sysmex focuses on extending the boundaries ofdiagnostic science while providing the management information tools that makea real difference in clinical and operational results for people worldwide.For more information about Sysmex, please visit http://www.sysmex.com/usa.
This release contains certain forward-looking statements within themeaning of the Private Securities Litigation Reform Act of 1995 and Section21E of the Securities Exchange Act of 1934. Forward-looking statementsgenerally can be identified by the use of forward-looking terminology such as,"believe," "expect," "may," "will," "intend," "estimate," "continue," orsimilar expressions or the negative of those te
